Genmab A/S is a Danish A/S based in Valby, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1998, the company has 666 employees and reported revenue of DKK 3.7bn in its latest annual filing.
Solidity ratio Equity ÷ Total assets × 100 Around the average of companies in the same industry
2021 2025
Liquidity ratio Current assets ÷ Short-term debt Around the average of companies in the same industry
2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Around the average of companies in the same industry
2021 2025
EBITDA — year on year DKK millions 12B 8.7B 5.8B 2.9B 0B 2021: 3.3B 3.3B 2021 2022: 5.8B (+79% vs 2021) 5.8B +79% 2022 2023: 5.7B (-2% vs 2022) 5.7B -2% 2023 2024: 9.3B (+64% vs 2023) 9.3B +64% 2024 2025: 1.4B (-86% vs 2024) 1.4B -86% 2025
Key figures Annual report 2025 Revenue 3.7B DKK -83% EBITDA 1.4B DKK -86% Net profit 1.2B DKK -90% Total assets 13.4B DKK -72% Equity 6.7B DKK -84% Employees 666 —
Founded
11 June 1998 · 28 years
Share capital
DKK 62,377,844
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at udøve medicinsk forskning, produktion og salg af sådanne produkter samt anden dermed i forbindelse stående virksomhed.
(no translation available)
Address
Carl Jacobsens Vej 30, 2500
Valby Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in København All Denmark companiesFinancial development In its most recent annual report (2025), Genmab A/S reported revenue of DKK 3.7bn, a decrease of 83% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 1.2bn, and the EBITDA margin stood at 36.9%.
At the end of 2025, equity financed 50.2% of the balance sheet, and current assets covered short-term debt 2.4 times. Genmab A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Genmab A/S? Genmab A/S is registered with CVR / Virk under CVR 21023884.
What is the revenue of Genmab A/S? Genmab A/S reported revenue of DKK 3.7bn in 2025.
How many employees does Genmab A/S have? Genmab A/S employs 666 people as of the latest annual report.
Who is the CEO of Genmab A/S? Jan van de Winkel is the CEO of Genmab A/S, in role since 2010.
Who is the chairman of Genmab A/S? Deirdre Patrice Connelly chairs the board of Genmab A/S, in role since 2020.
Where is Genmab A/S headquartered? Genmab A/S's registered address is Carl Jacobsens Vej 30.